الصفحة الرئيسية>>Peptides>>Angiotensin II 5-valine

Angiotensin II 5-valine

رقم الكتالوجGC35354

أنجيوتنسين 2 5-فالين هو ناهض لمستقبلات الأنجيوتنسين

Products are for research use only. Not for human use. We do not sell to patients.

Angiotensin II 5-valine التركيب الكيميائي

Cas No.: 58-49-1

الحجم السعر المخزون الكميّة
5mg
42٫00
متوفر
10mM (in 1mL Water)
52٫00
متوفر
50mg
64٫00
متوفر
100mg
92٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Video Related Products

Angiotensin II 5-valine is an agonist of angiotensin receptor. Angiotensin receptor[1].

By day 12, systolic blood pressure (SBP) increases significantly in Angiotensin II 5-valine infused rats (197±7 mm Hg). As shown, the development of hypertension in ANG II infused rats is prevented by losartan treatment. Blood and kidney samples are harvested, subjected to HPLC to separate Angiotensin II 5-valine (exogenous) from Ile5-ANG II (endogenous) and the fractions are measured by radioimmunoassay. In the Angiotensin II 5-valine infused rats treated with losartan, total plasma ANG II levels are elevated to a greater extent than in rats not treated with losartan (289±20 v 119±14 fmol/mL). However, losartan markedly decrease by 88% the enhancement of intrarenal Val5-ANG II content that occurred in the rats infused with Val5-ANG II alone[1].

[1]. Zou LX et al. Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT1 receptor. Am J Hypertens. 1998 May;11(5):570-8.

مراجعات

Review for Angiotensin II 5-valine

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Angiotensin II 5-valine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.